Table S2 from Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer
Year: 2023
Type: other
Abstract: Mutations detected by cobas®, therascreen® pyro and highly-sensitive dPCR
Authors: Cristina Santos, Daniel Azuara, Rocio Garcia-Carbonero, Pilar Garcia Alfonso, Alfredo Carrato, Mª Elena Elez, Auxiliadora Gomez, Ferran Losa, Clara Montagut, Bartomeu Massuti, Valenti Navarro, Mar Varela, Adriana Lopez-Doriga, Victor Moreno, Manuel Valladares, Jose Luis Manzano, Jose Maria Vieitez, Enrique Aranda, Xavier Sanjuan, Josep Tabernero, Gabriel Capella, Ramon Salazar
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362484994